Gene · 4607
NIH grants2,246
NIH grants whose papers are about the gene, through NIH's grant-paper links.
561 to 580 of 2,246
Download this page as JSON| Grant | Title | MYBPC3 papers | Newest fiscal year |
|---|---|---|---|
| R01DK116750 | Mechanisms of NAT2 Regulation of Insulin Resistance and Mitochondrial Dysfunction | 1 | 2023 |
| R01DK118427 | Genome, Metabolome, Ancestry and Diabetes Health Disparity | 1 | 2023 |
| R01DK120565 | Characterization of novel insulin resistance genes by gene editing, high-throughput phenotyping and in vivo studies | 1 | 2023 |
| R01EY030851 | Integration of clinical measures and theoretical modeling to quantify sectorial specific changes in ocular structure, function, and hemodynamics | 1 | 2023 |
| R01HL103866 | Gut Flora metabolism of dietary carnitine and cardiovascular disease | 1 | 2023 |
| R01HL109942 | Genetic Predisposition To Thoracic Aortic Aneurysms/Dissections | 1 | 2023 |
| R01HL114910 | Mechanisms of Right Ventricular Dysfunction in Scleroderma-associated PAH | 1 | 2023 |
| R01HL139755 | Cellular Reductive State Regulates Arteriogenesis | 1 | 2023 |
| R01HL143067 | Transcriptional regulation of cardiac pathological remodeling by REV-ERBα | 1 | 2023 |
| R01HL145534 | Cardiac Myosin Binding Protein-C in Development and Reversal of Heart Failure | 1 | 2023 |
| R01HL146158 | Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF) | 1 | 2023 |
| R01HL148609 | Functional interaction between cardiac Na channels and KATP channels | 1 | 2023 |
| R01HL149363 | Cardiac Mechanisms of Sudden Unexpected Death in Epilepsy | 1 | 2023 |
| R01HL151078 | The Role of Donor Innate Immune Responses in Regulating Alloimmunity after Heart Transplantation | 1 | 2023 |
| R01HL151345 | Targeting Ketone Metabolism as a Novel Heart Failure Therapy | 1 | 2023 |
| R01HL151737 | Cell type-Specific Therapeutic Targeting of canonical WNT Pathway in Arrhythmogenic Cardiomyopathy | 1 | 2023 |
| R01HL152201 | Development of a whole heart model of the J wave syndromes and novel approaches to pharmacologic management of associated life-threatening arrhythmias | 1 | 2023 |
| R01HL153220 | Critical Role of TBX20 in Cardiomyocyte Maturation during Direct Cardiac Reprogramming | 1 | 2023 |
| R01MH115958 | 1/7 Collaborative Genomic Studies of Tourette Disorder. | 1 | 2023 |
| R21HL161718 | Application of a novel polygenic risk score to the study of diabetic cardiomyopathy in diverse populations | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4607/grants?page=29